Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post-acute-care setting.
Infect Control Hosp Epidemiol
; 44(7): 1159-1162, 2023 Jul.
Article
em En
| MEDLINE
| ID: mdl-35896514
ABSTRACT
We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed among 9.9% and 9.1% of isolates, respectively. Nonsusceptibility to ceftazidime-avibactam (1.1%) and plazomicin (0.8%) were uncommon.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ceftazidima
/
Klebsiella pneumoniae
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article